As the country continues to grapple with a mental health crisis, it may not be a surprise to learn that according to the National Institute of Mental Health, more than 21 million American adults have ...
A single dose of an experimental psilocybin drug offered significant sustained improvement in symptoms and disability in patients with major depressive disorder (MDD) over a 6-week period, a new study ...
Just one dose of psilocybin significantly improved depression symptoms and functional disability in patients with major depressive disorder (MDD), a randomized trial found. Administered with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. One psilocybin dose reduced depression and functional ...
A recent study published in Nature Communications may have an answer. It found that women have a higher genetic risk of ...
SAN DIEGO, Sept. 16, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present new data from the Phase 2 SAVITRI study of osavampator in adults with major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback